Xuewei Zhu

4.2k citations
73 papers · 3.3k indexed · h-index 30

Xuewei Zhu

72 papers receiving 3.3k citations

Peers

Xuewei Zhu
Comparison fields: 5 of 114
  • Immunology 879
  • Biological Psychiatry 99
  • Cancer Research 486
  • Surgery 1.0k
  • Molecular Biology 1.6k
Replace Xiaoni Kong with:
Xiaoni Kong China
Dechun Feng United States
Adam E. Mullick United States
Cynthia Ju United States
Elizabeth J. Tarling United States
Ji Miao China
Ebru Erbay United States
Hidemi Yoshida Japan
Melek C. Arkan Germany
Xuewei Zhu relative to Xiaoni Kong China Xiaoni Kong's profile →
Citations per field
00.5×1.5×2.2×
Xiaoni Kong · 1×
Citations per year

Countries citing papers authored by Xuewei Zhu

Since Specialization
Citations

This map shows the geographic impact of Xuewei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Zhu more than expected).

Fields of papers citing papers by Xuewei Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Zhu. The network helps show where Xuewei Zhu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xuewei Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuewei Zhu Line = papers co-authored together Xuewei Zhu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202513
2 20241
3 20234
4 20231
5 202330
6 20235
7 20219
8 202022
9 202015
10 201931
11 201778
12 201519
13 201517
14 201529
15 201337
16 201257
17 2012132
18 2012102
19 2010275
20 200626

About Xuewei Zhu

Xuewei Zhu is a scholar working on Biological Psychiatry, Immunology and Allergy, Clinical Biochemistry, Cancer Research and Nutrition and Dietetics, having authored 73 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (18 papers), Peroxisome Proliferator-Activated Receptors (13 papers), Drug Transport and Resistance Mechanisms (10 papers), Fatty Acid Research and Health (8 papers), Inflammasome and immune disorders (6 papers), Asthma and respiratory diseases (6 papers), Allergic Rhinitis and Sensitization (5 papers) and Diet and metabolism studies (5 papers). The work is most often cited by research in Immunology (879 citations), Biological Psychiatry (99 citations), Cancer Research (486 citations), Surgery (1.0k citations) and Molecular Biology (1.6k citations). Xuewei Zhu has collaborated with scholars based in United States, China and France. Frequent co-authors include John S. Parks, Michael J. Thomas, Elizabeth M. Hiltbold, Elena Boudyguina, J.S. Owen, Martha D. Wilson, Abraham K. Gebre, Michael B. Fessler, Zhan Wang and J. Mark Brown. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Leukocyte Biology and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026